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First molecular genetic test for a common 
inherited disease in companion animals 
Small animal practitioners, breed­
ers. and pet owners recognize that inher­
ited disorders occur commonly and are a 
major problem in companion animals. 
Over 400 hereditary diseases have now 
been reponed in dogs; many of them are 
breed-specific and may occur frequently 
in a particular breed due to inbreeding or 
linebreeding practices. Most genetic dis­
orders are inherited as autosomal reces­
sive traits, i.e., affected puppies of both 
genders have two mutant genes and 
result from matings of healthy parents 
that e<Jch carry a normal and mut'dnt gene 
(carriers). 
Each inherited disorder presents 
with typical signs early in life, and the 
disease cour e is usually chronic, 
although intermittent and late onset pre­
sentations are seen with some defects. 
Since other diseases may cause similar 
clinical signs. routine and special labora­
tory tests are generally required to con­
firm a clinical diagnosis. For the control 
and eradication of genetic diseases it is 
also important not only to recognize 
affected animals. but also to identify car­
riers among littermates and ot.her rela­
tives of diseased animals. Parents of 
affected animals are obligate carriers. 
Unfonunately. laboratory tests to screen 
for healthy carriers are only available for 
a few inherited diseases in companion 
animals. They are usually cumbersome 
and technically demanding. and do not 
always permit a reliable differentiation 
between carriers and normals. 
The first molecular genetic screen­
ing test for a common inherited disease 
in companion animals has been devel­
oped by Dr. Urs Giger's laboratory in the 
Section of Medical Genetics at the 
School of Veterinary Medicine. 
University of Pennsylvania. The test 
identifies carriers and affected dogs with 
phosphofructokinase (PFK) deficiency. 
Less than a decade ago, Dr. Giger, 
associate professor of medicine and med­
ical genetics, first described PFK defi­
ciency in English springer spaniels. PFK. 
a major regulatory enzyme in all cells of 
Lhe body, catalyzes the metabolism of 
sugar and is pivotal in the production of 
enerey ro m�intain nonn::t l ce:ll fllncrion. 
Dogs with this enzyme deficiency have 
diseased red blood cells and muscle cells. 
PFK deficiency can present as a 
mild to life-threatening episodic illness. 
A hallmark sign of this disease is inter­
mittent dark urine, with the color of the 
urine ranging from orange to dark cof­
fee-brown, which commonly develops 
following strenuous e!(ercise. prolonged 
barking. and extensive panting. These 
conditions accelerate the destruction of 
red blood cells in affected dogs, resulting 
in dark brown urine, and in severe fonns, 
pale gums (anemia) or jaundice (yellow 
coloration of skin and gums) with fever 
and poor appetite. Particularly in field 
trial dogs, clinical signs of weakness, 
exercise intolerance, poor perfonnance 
to outright refusal to move, and muscle 
cramps may be observed. Clinical mani­
festations usually resolve within hours tO 
days. Affected dogs have a relatively 
nonnallife expectancy, however, situa­
tions tlnat can precipitate such crises 
should be avoided. 
This disorder is inherited as an 
autosomal recessive trait and has now 
been identified in over 50 English 
springer spaniels. It appears to be more 
common in the field trial line than in 
show dogs, but the true frequency of 
affected and carrier dogs is not known, 
Furthennore, the same disease has also 
recent! y been found in an American 
cocker spaniel. 
Dr. Bruce F. Smith, a graduate stu­
dent and Kleberg fellow in Medical 




Dr.�. Smil/1 and Citger with a PFK a/fi!C'Ii'd £ngltsh 
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discovered Lhat PFK deficiency and the 
associated clinical features are caused by 
a single base pair change (mutation) in 
the genetic code of the gene for this 
enzyme. Thus far. only a handful of 
hereditary diseases in the dog have been 
characterized at the molecular level, PFK 
deficiency being the first common hered­
itary disorder. 
Such genetic infom1arion is needed 
to better understand the mechanism of 
the disease process, and is essential to 
establish mutation-specific screening 
tests. The molecular genetic screening 
test for PFK deficiency developed by the 
Penn researchers is accurate in detennin­
ing whether a dog is nonnal, affected. or 
a carrier. The test reveals two mutant 
PFK gene copies in affected dogs, one 
mutant and one normal PFK gene copy 
in carriers. and two nonnal PFK gene 
copies in nonnal dogs. 
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The test requires only a few drops 
of blood from which the genetic code 
(DNA) is extracted and tested for the 
presence of the mutation by a poly­
merase chain reaction, a modern labora­
tory technique. Dogs can be tested at any 
age, even right after birth, allowing early 
determination of whether an animal has 
affected, carrier. or normal status. 
Because of the intermittent and 
variable clinical signs and the suspected 
high prevalence of PFK deficiency in the 
English springer spaniel breed. Dr. Giger 
recommends the resting of all English 
Springer spaniels with suggestive clinical 
signs and all springers used for field tri­
aling or breeding, or prior to purchase of 
a springer puppy. Affected dogs should 
not b e  bred, and appropriate precautions 
taken to ensure their health and welfare. 
It is not recommended that carrier dogs 
be used for breeding; however, if they 
are bred, they should only be bred to 
dogs tested as normal, and all of the 
resulting puppies should be tested. 
Carrier puppies should be neutered and 
National Award for Penn Researcher 
A Burroughs WeUcome Fund New 
Investigator Award in Molecular 
Parasitology for I 993 was awarded to 
Or. Phillip Scott, assistant professor of 
parasitology at the University of Penn­
sylvania School of Veterinary Medicine. 
The $60,000 award, provided over two 
years, will enable Dr. Scott to continue 
his work on the development of a vac­
cine against leishmaniasis. This disease, 
caused by a parasite. affects man and 
animals in Central and South America, 
Africa, southern Europe and the Middle 
East. If not treated it can cause severe 
disfigurement and even death. 
Dr. Scott's research focuses on 
studying the immune responses associ­
ated with the parasite, Leishmania. The 
foundation for the studies are Dr. Scon's 
observations that the stimulation of dif­
ferent types of immune cells determine 
Whether the parasite is eliminated, or 
whether the infection is eventually fatal. 
These findings are usefuJ not only in 
understanding leishmaniasis but also in 
understanding immunity in several other 
diseases, since these different cell types 
are important in controlling many infec­
tious diseases, including parasitic, bacte­
rial and viral infections, as well as aller­
gies and autoimmune disease. Thus 
advances made in the leishmania! model 
may be widely applicable. 
rn the past, vaccine development 
has been. for the most part. done empiri­
cally. Dr. Scott's research will involve 
2 
identification of molecules that act to 
stimulate the development of particular 
types of immune cells. With this knowl­
edge. it is thought that researchers may 
be able to design vaccines of the future 
more rationaJiy. 
The Molecular Parasitology Award 
Program is offered annually by The 
Burroughs Wellcome Fund to recognize 
the pioneering contributions of Sir Henry 
Wellcome to the study of tropical medi­
cine. and to support the applicaLion of 
modem developments in biology and 
normal puppies used to continue the 
breeding program. By testing and breed­
ing appropriately, PFK deficiency can be 
rapidly eliminated from this breed, and 
the further spread of this disease and 
future suffering of affected animals can 
be prevented. 
For further information on testing 
dogs, please contact Drs. Urs Giger/Beth 
Callan, School of Veterinary Medicine, 
University of Pennsylvania. 3850 Spruce 
Street, Philadelphia, PA 19l04-6010 
(FAX 215-573-'2162). 
chemistry to the understanding, control 
and prevention of parasitic diseases. 
Dr. Scott is the first researcher 
associated with a veterinary school to 
receive the award. Two other 1993 New 
Investigator awards were presented to 
scientists at other institutions. 
The Burroughs Wellcome Fund is a 
private, non-profit foundation estab­
lished in 1955 ''To provide financial aid 
for the advancement of medical knowl­
edge by research. and for other scientific. 
scholarly and educational purposes:· 
